Canada
Public Health Agency of Canada
Vaccine safety surveillance, Thrombosis with thrombocytopenia syndrome (TTS), adverse events following immunization, adenovirus vector COVID-19 vaccines, observed versus expected analysis, ChAdOx1-S [recombinant], Ad26.COV2.S